Paper40862425
Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK/SIRT1 and Nrf2/HO-1 signaling pathway.
Shen Q and 5 others. Acta Cir Bras, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK/SIRT1 and Nrf2/HO-1 signaling pathway. Papers, record 40862425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40862425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK/SIRT1 and Nrf2/HO-1 signaling pathway.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Non-alcoholic Fatty Liver Disease | Major topic |
| Sirtuin 1 | Major topic |
| NF-E2-Related Factor 2 | Major topic |
| Plant Leaves | Major topic |
| Plant Extracts | Major topic |
| Animals | |
| Signal Transduction | |
| Male | |
| AMP-Activated Protein Kinases | |
| Oxidative Stress | |
| Diet, High-Fat | |
| Liver | |
| Rats, Wistar | |
| Rats | |
| Cytokines | |
| Heme Oxygenase (Decyclizing) | |
| Protective Agents | |
| Disease Models, Animal | |
| Heme Oxygenase-1 |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36203933 | The AMPK pathway in fatty liver disease. | Front Physiol | 2022 | https://conductscience.org/library/papers/36203933 | PubMed |
| 2 | 25372397 | Antioxidant and anticancer aporphine alkaloids from the leaves of Nelumbo nucifera Gaertn. cv. Rosa-plena. | Molecules | 2014 | https://conductscience.org/library/papers/25372397 | PubMed |
| 3 | 29633106 | Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate. | Inflammopharmacology | 2018 | https://conductscience.org/library/papers/29633106 | PubMed |
| 4 | 34371577 | Phytochemical Screening, Antioxidant and Sperm Viability of Nelumbo nucifera Petal Extracts. | Plants (Basel) | 2021 | https://conductscience.org/library/papers/34371577 | PubMed |
| 5 | 24489777 | Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. | PLoS One | 2014 | https://conductscience.org/library/papers/24489777 | PubMed |
| 6 | 35689859 | Extract of Jasminum grandiflorum L. alleviates CCl4-induced liver injury by decreasing inflammation, oxidative stress and hepatic CYP2E1 expression in mice. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35689859 | PubMed |
| 7 | 33662429 | SET8 mitigates hepatic ischemia/reperfusion injury in mice by suppressing MARK4/NLRP3 inflammasome pathway. | Life Sci | 2021 | https://conductscience.org/library/papers/33662429 | PubMed |
| 8 | 37979064 | Obesity and Dyslipidemia. | Curr Atheroscler Rep | 2023 | https://conductscience.org/library/papers/37979064 | PubMed |
| 9 | 24454330 | Dyslipidemia in rat fed with high-fat diet is not associated with PCSK9-LDL-receptor pathway but ageing. | J Geriatr Cardiol | 2013 | https://conductscience.org/library/papers/24454330 | PubMed |
| 10 | 39243432 | Berberine alleviates fructose-induced hepatic injury via ADK/AMPK/Nrf2 pathway: A novel insight. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/39243432 | PubMed |
| 11 | 38203796 | The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38203796 | PubMed |
| 12 | 33425700 | Anti-aging potential and phytochemicals of Centella asiatica, Nelumbo nucifera, and Hibiscus sabdariffa extracts. | J Adv Pharm Technol Res | 2020 | https://conductscience.org/library/papers/33425700 | PubMed |
| 13 | 38647851 | Lotus (Nelumbo nucifera): a multidisciplinary review of its cultural, ecological, and nutraceutical significance. | Bioresour Bioprocess | 2024 | https://conductscience.org/library/papers/38647851 | PubMed |
| 14 | 38036934 | Regulation and targeting of SREBP-1 in hepatocellular carcinoma. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/38036934 | PubMed |
| 15 | 38076077 | Exfoliation and physico-chemical characterization of novel bioplasticizers from Nelumbo nucifera leaf for biofilm application. | Heliyon | 2023 | https://conductscience.org/library/papers/38076077 | PubMed |
| 16 | 35757691 | The Role of NLRP3 Inflammasome Activation Pathway of Hepatic Macrophages in Liver Ischemia-Reperfusion Injury. | Front Immunol | 2022 | https://conductscience.org/library/papers/35757691 | PubMed |
| 17 | 20041406 | Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. | Hepatology | 2010 | https://conductscience.org/library/papers/20041406 | PubMed |
| 18 | 31165007 | The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases. | Aging Dis | 2019 | https://conductscience.org/library/papers/31165007 | PubMed |
| 19 | 35542112 | Deconvoluting the dual hypoglycemic effect of wedelolactone isolated from Wedelia calendulacea: investigation via experimental validation and molecular docking. | RSC Adv | 2018 | https://conductscience.org/library/papers/35542112 | PubMed |
| 20 | 32149275 | Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. | JHEP Rep | 2019 | https://conductscience.org/library/papers/32149275 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939910 | Phenolic Profiles and Antioxidant Potential of Nymphaea and Nelumbo Species: Botanical Authentication, Redox-Modulating Mechanisms, and Translational Perspectives. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42939910 | PubMed |
| 42051254 | Preclinical evaluation of puerarin for the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42051254 | PubMed |
| 41614829 | Chemical Composition and Bioactivity of Nelumbo nucifera Gaertn. Flower Extract Fractions: In Vitro Antioxidant and Anti-Inflammatory Properties. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41614829 | PubMed |
| 41222323 | Green-Synthesized Silver Nanoparticles from Garlic Peel Target NF-κB and Redox Imbalance: A Novel Therapeutic Strategy Against Pyrogallol-Induced Hepatotoxicity in Rats. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/41222323 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40862425
GET https://conductscience.org/api/papers/v1/40862425/references?page=2